Growth Metrics

Humana (HUM) Notes Payables (2016 - 2025)

Humana has reported Notes Payables over the past 17 years, most recently at $306.0 million for Q4 2025.

  • Quarterly results put Notes Payables at $306.0 million for Q4 2025, down 24.07% from a year ago — trailing twelve months through Dec 2025 was $306.0 million (down 24.07% YoY), and the annual figure for FY2025 was $306.0 million, down 24.07%.
  • Notes Payables for Q4 2025 was $306.0 million at Humana, down from $308.0 million in the prior quarter.
  • Over the last five years, Notes Payables for HUM hit a ceiling of $457.0 million in Q2 2023 and a floor of $236.0 million in Q2 2021.
  • Median Notes Payables over the past 5 years was $329.5 million (2021), compared with a mean of $329.0 million.
  • Biggest five-year swings in Notes Payables: surged 102.96% in 2021 and later dropped 24.07% in 2025.
  • Humana's Notes Payables stood at $326.0 million in 2021, then fell by 8.59% to $298.0 million in 2022, then increased by 18.46% to $353.0 million in 2023, then increased by 14.16% to $403.0 million in 2024, then fell by 24.07% to $306.0 million in 2025.
  • The last three reported values for Notes Payables were $306.0 million (Q4 2025), $308.0 million (Q3 2025), and $298.0 million (Q2 2025) per Business Quant data.